The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prophylactic ciprofloxacin to prevent febrile neutropenia in adjuvant breast cancer patients receiving docetaxel (nonanthracycline) regimens.
Meena Okera
No relevant relationships to disclose
Ben W. Stevenson
No relevant relationships to disclose
Brian N. Stein
No relevant relationships to disclose
Nimit Singhal
No relevant relationships to disclose
Francis Parnis
No relevant relationships to disclose
Kerry A. Cheong
No relevant relationships to disclose
Carolyn L. Bampton
No relevant relationships to disclose
Sarwan K. Bishnoi
No relevant relationships to disclose
Dusan Kotasek
No relevant relationships to disclose